Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 12Cetuximab 12Chemotherapy, Adjuvant 11Bevacizumab 9Neoadjuvant Therapy 8Drug Therapy 8XELOX 7Laparoscopy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2Simvastatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × orantinib × Clear all
NCT00024063 2013-12-19

SU006668 in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
BreastGastrointestinalGenitourinaryPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡